• For Institutions

    • Corporate Services
    • Developers
  • Download
  • Help
  • About

    • Company Profile
    • License & Regulatory
    • Media coverage
longbridgelongbridge
longbridgelongbridge
Products
Pricing
Markets
Global Markets
Stock Screener
Information
Insights
News
Live
Academy
Affiliate Program
Promotions
PortAI
EN
English
简体中文
繁體中文
繁體中文(廣東話)Posts & comments will be shown in Cantonese
Search...
Quote ListQuote List
Overview
News
Financials
© 2025 Longbridge|Disclaimer

Event Tracking

Nov11
Editas Medicine released FY2025 9 Months Earnings on November 10, 2025 (EST) with actual revenue of USD 15.78 M and EPS of USD -1.8255
04:00
Editas Medicine released FY2025 Q3 earnings on November 10 (EST), actual revenue USD 7.543 M (forecast USD 4.945 M), actual EPS USD -0.2787 (forecast USD -0.3121)
04:00
Oct6
Editas Medicine to Report CRISPR Gene Editing Drug Data at ESGCT Conference
13:00
Aug13
Editas Medicine released FY2025 Semi-Annual earnings on August 12 (EST), actual revenue USD 8.236 M, actual EPS USD -1.5443
03:00
Editas Medicine released FY2025 Q2 earnings on August 12 (EST), actual revenue USD 3.578 M (forecast USD 1.805 M), actual EPS USD -0.6306 (forecast USD -0.3836)
03:00
Jul3
Editas Medicine Showcases Progress in Gene Editing for Beta Thalassemia and Sickle Cell Disease
13:20

Schedules & Filings

Schedules
Filings
Nov10
Earning Release(EST)

FY2025 Q3 Earning Release (USD) Revenue 7.543 M, Net Income -25.12 M, EPS -0.2787

Aug12
Earning Release(EST)

FY2025 Q2 Earning Release (USD) Revenue 3.578 M, Net Income -53.24 M, EPS -0.6306

May12
Earning Release(EST)

FY2025 Q1 Earning Release (USD) Revenue 4.658 M, Net Income -76.09 M, EPS -0.9161

View More

Stock List

Top Gainers
Top Decliners
China Concepts
Symbol
Price
%Chg
Change
ASPC
24.010
+78.91%
+10.590
PCLA
0.4050
+74.49%
+0.173
DTCK
0.3951
+66.08%
+0.157
SOPA
1.820
+58.26%
+0.670
ECDA
1.150
+46.50%
+0.365
GAUZ
1.470
+44.12%
+0.450
CELG.RT
0.0698
+39.60%
+0.020
ASPCR
0.2500
+38.89%
+0.070
PAVS
2.170
+37.34%
+0.590
CUE
0.3248
+34.77%
+0.084
View More